GEISTWERT Rechtsanwälte Lawyers Avvocati

ORD_69280/2024

10x Genomics, Inc. v. Curio Bioscience, Inc

Datum
2025-06-16
Kammer
Düsseldorf (DE) Local Division
Verfahrensart
Infringement Action
Sprache
EN

Metadaten

Fall-IDORD_69280-2024-b19caf8cf94a
Aktenzeichen
RegisterzeichenORD_69280/2024
EntscheidungsreferenzORD_69280/2024
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 38

Düsseldorf Local Division UPC_CFI_140/2024 Decision of the Court of First Instance of the Unified Patent Court delivered on 16 June 2025 concerning EP 2 697 391 B1 Headnotes: As claim construction is a matter of law and the Court must independently construe the claims (UPC_CoA_768/2024, Order of 30 April 2025, Headnote 1 Insulet Corporation v EOFlow), the first reference to (further) subclaims at the oral hearing may be admissible provided that the feature in question was already in dispute and the subclaims merely provide additional arguments in Keywords: Claim construction; patent specification 2 CLAIMANT: 10x Genomics, Inc. , legally represented by the Board of Directors, this represented by the CEO Serge Saxonov , 6230 Stoneridge Mall Road, 94588-3260 Pleasanton, CA, USA represented by ...